Get competitive research for biopharma

Overview

Biopharma and healthcare teams often need a fast, reliable view of a drug’s competitive landscape, including approvals and how patients feel about each option. Perplexity turns a single question about Cosentyx into a structured competitive and sentiment snapshot you can actually use in strategy decks or research briefs.

Your search

You ask Perplexity:

Give me a list of Cosentyx's competitors, the dates when they were FDA approved, and positive and negative customer sentiment for each.

Perplexity pulls together major biologic and small‑molecule competitors across psoriasis and psoriatic disease, then layers in FDA approval timing and patient‑reported themes from reviews and market commentary.

Perplexity’s answer

Perplexity responds with a clear competitor table that includes each brand/generic name, company, mechanism, first FDA approval year for psoriasis/psoriatic indications, and directional positive vs negative patient sentiment. It surfaces the key players like Taltz, Skyrizi, Humira, Enbrel, Stelara, Tremfya, Siliq, and Otezla and summarizes how patients talk about efficacy, convenience, side effects, and access pain points.

You also get important caveats around bias in patient reviews and suggestions for deeper next steps, such as building an NPS‑style grid or focusing on plaque psoriasis only. This makes it much easier to translate raw feedback into message testing inputs, positioning angles, or follow‑up market research questions.

Expand

Expand

Tips

• Narrow in: “Focus only on plaque psoriasis and add a column for perceived efficacy vs Cosentyx.”
• Ask for different cuts: “Group these competitors by mechanism class and summarize sentiment for each class.”
• Turn into slides: “Translate this table into three bullets for an executive competitive overview.”
• Go deeper on risk: “Highlight where boxed warnings or side‑effect themes show up most strongly in patient sentiment.”